MAGEC3 and ovarian cancer: They found by exome sequencing of 159 non-BRCA1/2 ovarian cancer cases that one missense variant (rs176026 in MAGEC3) was associated with risk at “chromosome-wide significance” (Hazard ratio [HR] = 2.85, 95% CI 1.75–4.65) and with a 6.7-year-earlier age of onset.